|
|
| November 14, 2016: Dr. C. Michael Gibson Presents: PIONEER AF-PCI: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO T |
Dr. C. Michael Gibson Presents: PIONEER AF-PCI: An OPen-label, Randomized, Controlled,
Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted
Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who
Undergo Percutaneous Coronary Intervention
TBD
[ Download video ] |
|
No comments have been submitted
|